The price-to-earnings ratio for Organon & Co (NYSE: OGN) is 3.16x, which is above its average ratio. Moreover, the 36-month beta value for OGN is 0.68. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 3 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for OGN is 259.08M and currently, short sellers hold a 6.73% of that float. On May 07, 2025, OGN’s average trading volume was 4.82M shares.
OGN) stock’s latest price update
Organon & Co (NYSE: OGN) has seen a rise in its stock price by 4.70 in relation to its previous close of 8.72. However, the company has experienced a -30.62% decline in its stock price over the last five trading sessions. accessnewswire.com reported 2025-05-06 that NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. (“Organon & Co.”) (NYSE:OGN) concerning possible violations of federal securities laws. On May 1, 2025, Organon reported mixed Q1 FY25 results, missing expectations on revenue decline of 7% y/y to $1.51B.
OGN’s Market Performance
OGN’s stock has fallen by -30.62% in the past week, with a monthly drop of -30.04% and a quarterly drop of -38.89%. The volatility ratio for the week is 10.00% while the volatility levels for the last 30 days are 7.50% for Organon & Co The simple moving average for the last 20 days is -18.69% for OGN stock, with a simple moving average of -44.98% for the last 200 days.
Analysts’ Opinion of OGN
JP Morgan, on the other hand, stated in their research note that they expect to see OGN reach a price target of $20, previously predicting the price at $18. The rating they have provided for OGN stocks is “Underweight” according to the report published on September 06th, 2024.
Goldman gave a rating of “Neutral” to OGN, setting the target price at $16 in the report published on November 03rd of the previous year.
OGN Trading at -32.05% from the 50-Day Moving Average
After a stumble in the market that brought OGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.48% of loss for the given period.
Volatility was left at 7.50%, however, over the last 30 days, the volatility rate increased by 10.00%, as shares sank -27.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -39.46% lower at present.
During the last 5 trading sessions, OGN fell by -30.62%, which changed the moving average for the period of 200-days by -56.46% in comparison to the 20-day moving average, which settled at $11.23. In addition, Organon & Co saw -38.81% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OGN starting from WALSH MATTHEW M, who purchase 11,400 shares at the price of $8.82 back on May 05 ’25. After this action, WALSH MATTHEW M now owns 144,484 shares of Organon & Co, valued at $100,548 using the latest closing price.
Ali Kevin, the Chief Executive Officer of Organon & Co, purchase 34,000 shares at $8.80 during a trade that took place back on May 05 ’25, which means that Ali Kevin is holding 282,731 shares at $299,370 based on the most recent closing price.
Stock Fundamentals for OGN
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.57 for the gross margin
The net margin for Organon & Co stands at 0.12. The total capital return value is set at 0.13. Equity return is now at value 254.24, with 5.99 for asset returns.
Based on Organon & Co (OGN), the company’s capital structure generated 0.94 points at debt to capital in total, while cash flow to debt ratio is standing at 0.1. The debt to equity ratio resting at 16.52. The interest coverage ratio of the stock is 2.72.
Currently, EBITDA for the company is 1.61 billion with net debt to EBITDA at 5.61. When we switch over and look at the enterprise to sales, we see a ratio of 1.71. The receivables turnover for the company is 4.32for trailing twelve months and the total asset turnover is 0.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.67.
Conclusion
To wrap up, the performance of Organon & Co (OGN) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
